|
|
|
SB0212 Enrolled |
- 2 - |
LRB096 04753 RPM 14817 b |
|
|
1 |
| (225 ILCS 95/25 new)
|
2 |
| Sec. 25. Sexually Transmissible Disease Control Act. No |
3 |
| licensee under this Act may be disciplined for providing |
4 |
| expedited partner therapy in accordance with the provisions of |
5 |
| the Illinois Sexually Transmissible Disease Control Act. |
6 |
| Section 20. The Illinois Sexually Transmissible Disease |
7 |
| Control Act is amended by changing Sections 3 and 6 as follows:
|
8 |
| (410 ILCS 325/3) (from Ch. 111 1/2, par. 7403)
|
9 |
| Sec. 3. Definitions. As used in this Act, unless the |
10 |
| context clearly
requires otherwise:
|
11 |
| (1) "Department" means the Department of Public Health.
|
12 |
| (2) "Local health authority" means the full-time official |
13 |
| health
department of board of health, as recognized by the |
14 |
| Department, having
jurisdiction over a particular area.
|
15 |
| (3) "Sexually transmissible disease" means a bacterial, |
16 |
| viral, fungal or
parasitic disease, determined by rule of the |
17 |
| Department to be sexually
transmissible, to be a threat to the |
18 |
| public health and welfare, and to be a
disease for which a |
19 |
| legitimate public interest will be served by providing
for |
20 |
| regulation and treatment. In considering which diseases are to |
21 |
| be
designated sexually transmissible diseases, the Department |
22 |
| shall consider
such diseases as chancroid, gonorrhea, |
23 |
| granuloma inguinale, lymphogranuloma
venereum, genital herpes |
24 |
| simplex, chlamydia, nongonococcal urethritis
(NGU), pelvic |
|
|
|
SB0212 Enrolled |
- 3 - |
LRB096 04753 RPM 14817 b |
|
|
1 |
| inflammatory disease (PID)/Acute
Salpingitis, syphilis, |
2 |
| Acquired Immunodeficiency Syndrome (AIDS), and Human
|
3 |
| Immunodeficiency Virus (HIV) for designation, and shall |
4 |
| consider the
recommendations and classifications of the |
5 |
| Centers for Disease Control and
other nationally recognized |
6 |
| medical authorities. Not all diseases that are
sexually |
7 |
| transmissible need be designated for purposes of this Act.
|
8 |
| (4) "Health care professional" means a physician licensed |
9 |
| to practice medicine in all its branches, a physician assistant |
10 |
| who has been delegated the provision of sexually transmissible |
11 |
| disease therapy services or expedited partner therapy services |
12 |
| by his or her supervising physician, or an advanced practice |
13 |
| nurse who has a written collaborative agreement with a |
14 |
| collaborating physician that authorizes the provision of |
15 |
| sexually transmissible disease therapy services or expedited |
16 |
| partner therapy services, or an advanced practice nurse who |
17 |
| practices in a hospital or ambulatory surgical treatment center |
18 |
| and possesses appropriate clinical privileges in accordance |
19 |
| with the Nurse Practice Act. |
20 |
| (5) "Expedited partner therapy" means to prescribe, |
21 |
| dispense, furnish, or otherwise provide prescription |
22 |
| antibiotic drugs to the partner or partners of persons |
23 |
| clinically diagnosed as infected with a sexually transmissible |
24 |
| disease, without physical examination of the partner or |
25 |
| partners. |
26 |
| (Source: P.A. 85-1209.)
|
|
|
|
SB0212 Enrolled |
- 4 - |
LRB096 04753 RPM 14817 b |
|
|
1 |
| (410 ILCS 325/6) (from Ch. 111 1/2, par. 7406)
|
2 |
| Sec. 6. Physical examination and treatment.
|
3 |
| (a) Subject to the provisions of subsection (c) of this |
4 |
| Section, the
Department and its authorized representatives may |
5 |
| examine or cause to be
examined persons reasonably believed to |
6 |
| be infected with or to have been
exposed to a sexually |
7 |
| transmissible disease.
|
8 |
| (b) Subject to the provisions of subsection (c) of this |
9 |
| Section, persons
with a sexually transmissible disease shall |
10 |
| report for complete treatment to a
physician licensed under the |
11 |
| provisions of the Medical Practice Act of
1987, or shall submit |
12 |
| to treatment at a facility provided by a local health
authority |
13 |
| or other public facility, as the Department shall require by |
14 |
| rule or
regulation until the disease is noncommunicable or the |
15 |
| Department determines
that the person does not present a real |
16 |
| and present danger to the public
health. This subsection (b) |
17 |
| shall not be construed to require the Department
or local |
18 |
| health authorities to pay for or provide such treatment.
|
19 |
| (c) No person shall be apprehended, examined or treated for |
20 |
| a sexually
transmissible disease against his will, under the |
21 |
| provisions of this Act,
except upon the presentation of a |
22 |
| warrant duly authorized by a court of
competent jurisdiction. |
23 |
| In requesting the issuance of such a warrant the
Department |
24 |
| shall show by a preponderance of evidence that the person is
|
25 |
| infectious and that a real and present danger to the public |
|
|
|
SB0212 Enrolled |
- 5 - |
LRB096 04753 RPM 14817 b |
|
|
1 |
| health and
welfare exists unless such warrant is issued and |
2 |
| shall show that all other
reasonable means of obtaining |
3 |
| compliance have been exhausted and that no
other less |
4 |
| restrictive alternative is available. The court shall require
|
5 |
| any proceedings authorized by this subsection (c) to be |
6 |
| conducted in
camera. A record shall be made of such proceedings |
7 |
| but shall be sealed,
impounded and preserved in the records of |
8 |
| the court, to be made available
to the reviewing court in the |
9 |
| event of an appeal.
|
10 |
| (d) Any person who knowingly or maliciously disseminates |
11 |
| any false
information or report concerning the existence of any |
12 |
| sexually
transmissible disease under this Section is guilty of |
13 |
| a Class A misdemeanor.
|
14 |
| (e) Taking into account the recommendations of the U.S. |
15 |
| Centers for Disease Control and Prevention and other nationally |
16 |
| recognized medical authorities, the Department shall provide |
17 |
| information and technical assistance as appropriate to health |
18 |
| care professionals who provide expedited partner therapy |
19 |
| services for persons with sexually transmissible diseases. |
20 |
| (1) Notwithstanding any other provision of law, a |
21 |
| health care professional who makes a clinical diagnosis of |
22 |
| chlamydia or gonorrhea may prescribe, dispense, furnish, |
23 |
| or otherwise provide prescription antibiotic drugs to the |
24 |
| infected person's sexual partner or partners for the |
25 |
| treatment of the sexually transmissible disease without |
26 |
| physical examination of the partner or partners, if in the |
|
|
|
SB0212 Enrolled |
- 6 - |
LRB096 04753 RPM 14817 b |
|
|
1 |
| judgment of the health care professional the partner is |
2 |
| unlikely or unable to present for comprehensive |
3 |
| healthcare, including evaluation, testing, and treatment |
4 |
| for sexually transmissible diseases. Expedited partner |
5 |
| therapy shall be limited to partners who may have been |
6 |
| exposed to a sexually transmissible disease within the |
7 |
| previous 60 days, if the patient is able to contact the |
8 |
| partner. |
9 |
| (2) Health care professionals who provide expedited |
10 |
| partner therapy shall comply with Sections 4 and 5 of the |
11 |
| Illinois Sexually Transmissible Disease Control Act. |
12 |
| (3) Health care professionals who provide expedited |
13 |
| partner therapy shall provide counseling for the patient |
14 |
| and written materials provided by the Department to be |
15 |
| given by the patient to the partner or partners that |
16 |
| include at a minimum the following: |
17 |
| (A) a warning that a woman who is pregnant or might |
18 |
| be pregnant must not take certain antibiotics and must |
19 |
| immediately contact a health care professional for an |
20 |
| examination, and a recommendation for such an |
21 |
| examination; |
22 |
| (B) information about the antibiotic and dosage |
23 |
| provided or prescribed; clear and explicit allergy and |
24 |
| side effect warnings, including a warning that a |
25 |
| partner who has a history of allergy to the antibiotic |
26 |
| or the pharmaceutical class of antibiotic must not take |
|
|
|
SB0212 Enrolled |
- 7 - |
LRB096 04753 RPM 14817 b |
|
|
1 |
| the antibiotic and must be immediately examined by a |
2 |
| health care professional, and a recommendation for |
3 |
| such an examination; |
4 |
| (C) information about the treatment and prevention |
5 |
| of sexually transmissible diseases; |
6 |
| (D) the requirement of abstinence until a period of |
7 |
| time after treatment to prevent infecting others; |
8 |
| (E) notification of the importance of the partner |
9 |
| or partners of the patient to receive examination and |
10 |
| testing for HIV and other sexually transmissible |
11 |
| diseases, and available resources; |
12 |
| (F) notification of the risk to self, others, and |
13 |
| the public health if the sexually transmissible |
14 |
| disease is not completely and successfully treated; |
15 |
| (G) the responsibility of the partner or partners |
16 |
| to inform his or her sex partner or partners of the |
17 |
| risk of sexually transmissible disease and the |
18 |
| importance of prompt examination and treatment; and |
19 |
| (H) other information as deemed necessary by the |
20 |
| Department. |
21 |
| (4) The Department shall develop and disseminate in |
22 |
| electronic and other formats the following written |
23 |
| materials: |
24 |
| (A) informational materials for partners, as |
25 |
| required in item (3) of this subsection (e); |
26 |
| (B) informational materials for persons who are |
|
|
|
SB0212 Enrolled |
- 8 - |
LRB096 04753 RPM 14817 b |
|
|
1 |
| repeatedly diagnosed with sexually transmissible |
2 |
| diseases; and |
3 |
| (C) guidance for health care professionals on the |
4 |
| safe and effective provision of expedited partner |
5 |
| therapy. |
6 |
| The Department may offer educational programs about |
7 |
| expedited partner therapy for health care professionals |
8 |
| and pharmacists licensed under the Pharmacy Practice Act. |
9 |
| (5) A health care professional prescribing, |
10 |
| dispensing, furnishing, or otherwise providing in good |
11 |
| faith without fee or compensation prescription antibiotics |
12 |
| to partners under this subsection (e) and providing |
13 |
| counseling and written materials as required by item (3) of |
14 |
| this subsection (e) shall not be subject to civil or |
15 |
| professional liability, except for willful and wanton |
16 |
| misconduct. A health care professional shall not be subject |
17 |
| to civil or professional liability for choosing not to |
18 |
| provide expedited partner therapy. |
19 |
| (6) A pharmacist or pharmacy shall not be subject to |
20 |
| civil or professional liability for choosing not to fill a |
21 |
| prescription that would cause the pharmacist or pharmacy to |
22 |
| violate any provision of the Pharmacy Practice Act, |
23 |
| including the definition of "prescription" set forth in |
24 |
| subsection (e) of Section 3 of the Pharmacy Practice Act or |
25 |
| the definition of "drug regimen review" set forth in |
26 |
| subsection (y) of Section 3 of the Pharmacy Practice Act. |